 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 July 1999 | Volume 131 Issue 1 | Pages 7-13
Background: Hyperuricemia is associated with risk for cardiovascular disease and death. However, the role of uric acid independent of established risk factors is uncertain.
Objective: To examine the relation of serum uric acid level to incident coronary heart disease, death from cardiovascular disease, and death from all causes.
Design: Community-based, prospective observational study.
Setting: Framingham, Massachusetts.
Patients: 6763 Framingham Heart Study participants (mean age, 47 years).
Measurements: Serum uric acid level at baseline (1971 to 1976); event rates per 1000 person-years by sex-specific uric acid quintile.
Results: During 117 376 person-years of follow-up, 617 coronary heart disease events, 429 cardiovascular disease deaths, and 1460 deaths from all causes occurred. In men, after adjustment for age, elevated serum uric acid level was not associated with increased risk for an adverse outcome. In women, after adjustment for age, uric acid level was predictive of coronary heart disease (P = 0.002), death from cardiovascular disease (P = 0.009), and death from all causes (P = 0.03). After additional adjustment for cardiovascular disease risk factors, uric acid level was no longer associated with coronary heart disease, death from cardiovascular disease, or death from all causes. In a stepwise Cox model, diuretic use was identified as the covariate responsible for rendering serum uric acid a statistically nonsignificant predictor of outcomes.
Conclusions: These findings indicate that uric acid does not have a causal role in the development of coronary heart disease, death from cardiovascular disease, or death from all causes. Any apparent association with these outcomes is probably due to the association of uric acid level with other risk factors.
Author and Article Information
From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts; and Boston University School of Medicine, Boston, Massachusetts.
Grant Support: The Framingham Heart Study is supported by National Institutes of Health/National Heart, Lung, and Blood Institute contract N01-HC-38038. This investigation was supported in part by a research grant from Merck and Co., Inc. Dr. Culleton is a recipient of the 1997-1999 Kidney Foundation of Canada Fellowship.
Requests for Reprints: Daniel Levy, MD, Framingham Heart Study, 5 Thurber Street, Framingham, MA 01702; e-mail, Dan{at}fram.nhlbi.nih.gov.
Current Author Addresses: Dr. Culleton: Division of Nephrology, University of Calgary, Foothills Hospital, Room C-210, 1403 29th Street, Calgary, Alberta T2N 2T9, Canada.
Drs. Larson, Kannel, and Levy: Framingham Heart Study, 5 Thurber Street, Framingham, MA 01702. ARTICLE
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. Luque-Ramirez, F. Alvarez-Blasco, M. G. Uriol Rivera, and H. F. Escobar-Morreale Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin Hum. Reprod., July 1, 2008; 23(7): 1594 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meisinger, W. Koenig, J. Baumert, and A. Doring Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population: The MONICA/KORA Cohort Study Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1186 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Krishnan, K. Svendsen, J. D. Neaton, G. Grandits, L. H. Kuller, and for the MRFIT Research Group Long-term Cardiovascular Mortality Among Middle-aged Men With Gout Arch Intern Med, May 26, 2008; 168(10): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Qadan, A. A. Ahmed, H. A. Safar, M. A. Al-Bader, and A. A. Ali Prevalence of Metabolic Syndrome in Patients With Clinically Advanced Peripheral Vascular Disease Angiology, May 1, 2008; 59(2): 198 - 202. [Abstract] [PDF]
|
|
|
|
|
|
M. Gur, R. Yilmaz, R. Demirbag, and N. Aksoy Relation of Serum Uric Acid Levels With the Presence and Severity of Angiographic Coronary Artery Disease Angiology, May 1, 2008; 59(2): 166 - 171. [Abstract] [PDF]
|
|
|
|
 |
|
 Fuhua Peng, Bin Zhang, Xiufeng Zhong, Jin Li, Guihong Xu, Xueqiang Hu, Wei Qiu, and Zhong Pei Serum uric acid levels of patients with multiple sclerosis and other neurological diseases Multiple Sclerosis, March 1, 2008; 14(2): 188 - 196. [Abstract] [PDF]
|
|
|
|
 |
|
 S. D. Nath, V. S. Voruganti, N. H. Arar, F. Thameem, J. C. Lopez-Alvarenga, R. Bauer, J. Blangero, J. W. MacCluer, A. G. Comuzzie, and H. E. Abboud Genome Scan for Determinants of Serum Uric Acid Variability J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3156 - 3163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Schretlen, A. B. Inscore, T. D. Vannorsdall, M. Kraut, G. D. Pearlson, B. Gordon, and H. A. Jinnah Serum uric acid and brain ischemia in normal elderly adults Neurology, October 2, 2007; 69(14): 1418 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. F. Panoulas, H. J. Milionis, K. M. J. Douglas, P. Nightingale, M. D. Kita, R. Klocke, M. S. Elisaf, and G. D. Kitas Association of serum uric acid with cardiovascular disease in rheumatoid arthritis Rheumatology, September 1, 2007; 46(9): 1466 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Alderman Podagra, Uric Acid, and Cardiovascular Disease Circulation, August 21, 2007; 116(8): 880 - 883. [Full Text] [PDF]
|
|
|
|
|
|
H. K. Choi and G. Curhan Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease Circulation, August 21, 2007; 116(8): 894 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fukai Extracellular SOD Inactivation in High-Volume Hypertension: Role of Hydrogen Peroxide Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 442 - 444. [Full Text] [PDF]
|
|
|
|
|
|
K.-T. Wang, C.-Y. Chen, C. J.-Y. Hou, C.-H. Tsai, and H.-I Yeh Comparison of Clinical Characteristics of Acute Myocardial Infarction in Aborigines and Nonaborigines in Taitung Area of Taiwan Angiology, February 1, 2007; 58(1): 61 - 66. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Myllymaki, J. Syrjanen, H. Helin, A. Pasternack, A. Kattainen, and J. Mustonen Vascular diseases and their risk factors in IgA nephropathy Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1876 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Bos, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study Stroke, June 1, 2006; 37(6): 1503 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ruggiero, A. Cherubini, A. Ble, A. J.G. Bos, M. Maggio, V. D. Dixit, F. Lauretani, S. Bandinelli, U. Senin, and L. Ferrucci Uric acid and inflammatory markers Eur. Heart J., May 2, 2006; 27(10): 1174 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Lee, Y.-G. Kim, Y.-H. Choi, W. Huh, D. J. Kim, and H. Y. Oh Serum Uric Acid Is Associated With Microalbuminuria in Prehypertension Hypertension, May 1, 2006; 47(5): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwashima, T. Horio, K. Kamide, H. Rakugi, T. Ogihara, and Y. Kawano Uric Acid, Left Ventricular Mass Index, and Risk of Cardiovascular Disease in Essential Hypertension Hypertension, February 1, 2006; 47(2): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Suresh Diagnosis and management of gout: a rational approach Postgrad. Med. J., September 1, 2005; 81(959): 572 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck Lys418Asn Polymorphism of the {alpha}2-Adrenoceptor Gene Relates to Serum Uric Acid Levels But Not to Insulin Sensitivity Hypertension, July 1, 2005; 46(1): 144 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ishizaka, Y. Ishizaka, E.-I. Toda, R. Nagai, and M. Yamakado Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1038 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Viazzi, D. Parodi, G. Leoncini, A. Parodi, V. Falqui, E. Ratto, S. Vettoretti, G. P. Bezante, M. Del Sette, G. Deferrari, et al. Serum Uric Acid and Target Organ Damage in Primary Hypertension Hypertension, May 1, 2005; 45(5): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Arikan and S. Sen Endothelial Damage and Hemostatic Markers in Patients with Uncomplicated Mild-to-Moderate Hypertension and Relationship with Risk Factors Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 147 - 159. [Abstract] [PDF]
|
|
|
|
 |
|
 J. L Reid Review: Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension? Journal of Renin-Angiotensin-Aldosterone System, March 1, 2005; 6(1): 15 - 24. [Abstract] [PDF]
|
|
|
|
 |
|
 J. T. Wu and L. L. Wu Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 240 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sundstrom, L. Sullivan, R. B. D'Agostino, D. Levy, W. B. Kannel, and R. S. Vasan Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence Hypertension, January 1, 2005; 45(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Niskanen, D. E. Laaksonen, K. Nyyssonen, G. Alfthan, H.-M. Lakka, T. A. Lakka, and J. T. Salonen Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men: A Prospective Cohort Study Arch Intern Med, July 26, 2004; 164(14): 1546 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Samson Hypertension and the Vascular Patient Vascular and Endovascular Surgery, March 1, 2004; 38(2): 103 - 119. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Sanchez-Moreno, S. E. Dorfman, A. H. Lichtenstein, and A. Martin Dietary Fat Type Affects Vitamins C and E and Biomarkers of Oxidative Status in Peripheral and Brain Tissues of Golden Syrian Hamsters J. Nutr., March 1, 2004; 134(3): 655 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-P. Hsu, M.-F. Pai, Y.-S. Peng, C.-K. Chiang, T.-I Ho, and K.-Y. Hung Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients Nephrol. Dial. Transplant., February 1, 2004; 19(2): 457 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro, A. M. Planas, C. J. Weir, S. W. Muir, M. R. Walters, and K. R. Lees Yin and Yang of Uric Acid in Patients With Stroke * Response Stroke, January 1, 2004; 35 (1): e11 - e12. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oparil, M. A. Zaman, and D. A. Calhoun Pathogenesis of Hypertension Ann Intern Med, November 4, 2003; 139(9): 761 - 776. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A J. A. Khaja, R. P Sequeira, and A. H. Damanhori Treatment of Hypertension in Bahrain Ann. Pharmacother., October 1, 2003; 37(10): 1511 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sanchez-Moreno, M P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans Am. J. Clinical Nutrition, September 1, 2003; 78(3): 454 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Janssens, E. van de Lisdonk, H Bor, H. van den Hoogen, and M Janssen Gout, just a nasty event or a cardiovascular signal? A study from primary care Fam. Pract., August 1, 2003; 20(4): 413 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Weir, S. W. Muir, M. R. Walters, and K. R. Lees Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute Stroke Stroke, August 1, 2003; 34(8): 1951 - 1956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Rott and C. A. Agudelo Gout JAMA, June 4, 2003; 289(21): 2857 - 2860. [Full Text] [PDF]
|
|
|
|
 |
|
 T Bardin Fenofibrate and losartan Ann Rheum Dis, June 1, 2003; 62(6): 497 - 498. [Full Text] [PDF]
|
|
|
|
|
|
J. Kanellis, S. Watanabe, J. H. Li, D. H. Kang, P. Li, T. Nakagawa, A. Wamsley, D. Sheikh-Hamad, H. Y. Lan, L. Feng, et al. Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2 Hypertension, June 1, 2003; 41(6): 1287 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Guthikonda, C. Sinkey, T. Barenz, and W. G. Haynes Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers Circulation, January 28, 2003; 107(3): 416 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kuzuya, F. Ando, A. Iguchi, and H. Shimokata Effect of Aging on Serum Uric Acid Levels: Longitudinal Changes in a Large Japanese Population Group J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M660 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schafer, D. Pauleit, T. Sudhop, I. Gouni-Berthold, S. Ewig, and H. K. Berthold Body Fat Distribution, Serum Leptin, and Cardiovascular Risk Factors in Men With Obstructive Sleep Apnea* Chest, September 1, 2002; 122(3): 829 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Landmesser and H. Drexler Toward Understanding of Extracellular Superoxide Dismutase Regulation in Atherosclerosis: A Novel Role of Uric Acid? Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1367 - 1368. [Full Text] [PDF]
|
|
|
|
|
|
P. W. de Leeuw, L. Thijs, W. H. Birkenhager, S. M. Voyaki, A. D. Efstratopoulos, R. H. Fagard, G. Leonetti, C. Nachev, J. C. Petrie, J. L. Rodicio, et al. Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic Hypertension: Results from the Syst-Eur Trial J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2213 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. U. Hink, N. Santanam, S. Dikalov, L. McCann, A. D. Nguyen, S. Parthasarathy, D. G. Harrison, and T. Fukai Peroxidase Properties of Extracellular Superoxide Dismutase: Role of Uric Acid in Modulating In Vivo Activity Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1402 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yusuf and J. Bosch Urate levels as a predictor of cardiac deaths: causal relation or mere association? Eur. Heart J., May 2, 2002; 23(10): 760 - 761. [Full Text] [PDF]
|
|
|
|
|
|
K.Y.K. Wong, R.S. Macwalter, H.W. Fraser, I. Crombie, S.A. Ogston, and A.D. Struthers Urate predicts subsequent cardiac death in stroke survivors Eur. Heart J., May 2, 2002; 23(10): 788 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro, V. Obach, A. Cervera, M. Revilla, R. Deulofeu, and J. H. Aponte Prognostic Significance of Uric Acid Serum Concentration in Patients With Acute Ischemic Stroke Stroke, April 1, 2002; 33(4): 1048 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A D Struthers, P T Donnan, P Lindsay, D McNaughton, J Broomhall, and T M MacDonald Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study Heart, March 1, 2002; 87(3): 229 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Maxwell and K. A. Bruinsma Uric acid is closely linked to vascular nitric oxide activity: Evidence for mechanism of association with cardiovascular disease J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1850 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mazzali, J. Hughes, Y.-G. Kim, J. A. Jefferson, D.-H. Kang, K. L. Gordon, H. Y. Lan, S. Kivlighn, and R. J. Johnson Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism Hypertension, November 1, 2001; 38(5): 1101 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Padwal, S. E Straus, and F. A McAlister Evidence based management of hypertension: Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review BMJ, April 21, 2001; 322(7292): 977 - 980. [Full Text]
|
|
|
|
|
|
J.-G. Wang, J. A. Staessen, R. H. Fagard, W. H. Birkenhager, L. Gong, and L. Liu Prognostic Significance of Serum Creatinine and Uric Acid in Older Chinese Patients With Isolated Systolic Hypertension Hypertension, April 1, 2001; 37(4): 1069 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Verdecchia, G. Schillaci, G. Reboldi, F. Santeusanio, C. Porcellati, and P. Brunetti Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension : The PIUMA Study Hypertension, December 1, 2000; 36(6): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.S. Waring, D.J. Webb, and S.R.J. Maxwell Uric acid as a risk factor for cardiovascular disease QJM, November 1, 2000; 93(11): 707 - 713. [Full Text] [PDF]
|
|
|
|
|
|
J. Fang and M. H. Alderman Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992 JAMA, May 10, 2000; 283(18): 2404 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garg Gender Differences in the Prevalence of Metabolic Complications in Familial Partial Lipodystrophy (Dunnigan Variety) J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1776 - 1782. [Abstract] [Full Text]
|
|
|
|
Article
